Quantcast
Home > Quotes > APHB

AmpliPhi Biosciences Corporation Common Stock (APHB) Quote & Summary Data

APHB 
$0.26
*  
0.04
13.33%
Get APHB Alerts
*Delayed - data as of Nov. 14, 2018  -  Find a broker to begin trading APHB now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    APHB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
4.25
Today's High / Low
$ 0.3059 / $ 0.26
Share Volume
762,046
90 Day Avg. Daily Volume
424,511
Previous Close
$ 0.30
52 Week High / Low
$ 2.05 / $ 0.25
Market Cap
8,396,260
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.36

Intraday Chart

Shares Traded

Share Volume:
762,046
90 Day Avg. Daily Volume:
424,511

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.78

Trading Range

The current last sale of $0.26 is 4.00% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.3059 $ 2.05
 Low: $ 0.26 $ 0.25

Company Description (as filed with the SEC)

We are a biotechnology company pioneering the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. Phages have powerful and highly selective mechanisms of action that permit them to bind to and kill specific bacteria. We believe that phages represent a promising means to treat bacterial infections, especially those that have developed resistance to current therapies, including the so-called multi-drug-resistant or "superbug" strains of bacteria. The extensive use of antibiotics since the beginning of the modern antibiotics era in the 1940s has resulted in drug resistance among many disease-causing bacteria. According to the U.S. Centers for Disease Control and Prevention, or CDC, resistance to antibiotics threatens to reverse many of the key medical advances of the last half-century.  ... More ...  


Risk Grade

Where does APHB fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x